SCHEMBL27033384

SCHEMBL27033384

CC(C)c1c(O)cc(-c2cnc3ccccc3c2)cc1OS(=O)(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ MAP4K4 O95819 1/20 0.41
▸ CSNK1G2 P78368 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41
▸ MAP4K5 Q9Y4K4 1/20 0.41
▸ KDM5B Q9UGL1 1/20 0.41
▸ PDGFRB P09619 3/20 0.39
▸ PDGFRA P16234 2/20 0.39
▸ AKR1C3 P42330 1/20 0.38
▸ AKR1C2 P52895 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ BIRC5 O15392 1/20 0.37
▸ PIK3CD O00329 2/20 0.37
▸ PIK3CA P42336 2/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ MTOR P42345 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30726162 1.00 CA12 (0.45) CA12CA1CA2CA9MAP4K4
SCHEMBL27033260 0.93 CA12 (0.46) CA12CA1CA2CA9MAP4K4
SCHEMBL25521682 0.83 PDGFRB (0.51) CA12CA1CA2CA9MAP4K4
SCHEMBL31538928 0.83 PDGFRB (0.51) CA12CA1CA2CA9MAP4K4
SCHEMBL27033287 0.82 MAP4K4 (0.41) CA12CA1CA2CA9MAP4K4
SCHEMBL27033433 0.81 NPC1 (0.41) NPC1RAB9A
SCHEMBL27047682 0.76 PIK3CD (0.52) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL27033276 0.74 MAP4K4 (0.44) CA12CA1CA2CA9MAP4K4
SCHEMBL31538921 0.74 MAPT (0.34) MAP4K4MAPT
SCHEMBL27033314 0.74 MAPT (0.34) MAP4K4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558478-A1 ARYL HYDROCARBON RECEPTOR AGONIST PRODRUGS AND METHODS OF USE THEREOF Allianthera (Suzhou) Biopharmaceutical Co., Ltd. (CN) 2025-05-28 — — EP claimed
WO-2024020170-A1 ARYL HYDROCARBON RECEPTOR AGONIST PRODRUGS AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2024-01-25 — — WO claimed
EP-4558478-A1 ARYL HYDROCARBON RECEPTOR AGONIST PRODRUGS AND METHODS OF USE THEREOF Allianthera (Suzhou) Biopharmaceutical Co., Ltd. (CN) 2025-05-28 — — EP disclosed
WO-2024020170-A1 ARYL HYDROCARBON RECEPTOR AGONIST PRODRUGS AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2024-01-25 — — WO disclosed
WO-2024020170-A1 ARYL HYDROCARBON RECEPTOR AGONIST PRODRUGS AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2024-01-25 — — WO disclosed
Send feedback